In a patient with sudden‑onset vertigo and vomiting, which antiemetic is preferred: ondansetron or metoclopramide? | Rounds In a patient with sudden‑onset vertigo and vomiting, which antiemetic is preferred: ondansetron or metoclopramide? | Rounds
Loading...

In a patient with sudden‑onset vertigo and vomiting, which antiemetic is preferred: ondansetron or metoclopramide?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Antiemetic Choice in Sudden-Onset Vertigo With Vomiting

For sudden-onset acute vestibular syndrome, NICE focuses on urgent stroke exclusion and does not specify an antiemetic choice. [1] For ED patients with undifferentiated nausea and vomiting, intravenous ondansetron and intravenous metoclopramide were not more effective than placebo for nausea at 30 minutes. [2] Given the lack of clear comparative efficacy for this presentation and the adverse-effect profile, ondansetron is generally preferred over metoclopramide. [2], [3]

Medication Selection Algorithm

  • Ondansetron is preferred when selection is based on avoiding dopamine-receptor-antagonist extrapyramidal adverse effects. [3]
  • Metoclopramide may be used when clinical context supports its prokinetic properties or when ondansetron is contraindicated. [3]

Key Evidence Supporting This Recommendation

  • In a randomized, double-blind, placebo-controlled trial of 258 ED adults with nausea and vomiting, neither ondansetron (4 mg IV) nor metoclopramide (20 mg IV) improved nausea at 30 minutes compared with placebo. [2]

Monotherapy vs Combination Therapy

  • No evidence supports routine combination therapy between ondansetron and metoclopramide for sudden-onset vertigo-associated vomiting. [2]

Important Clarifications or Nuances

  • The cited ED trial population had undifferentiated causes of nausea and vomiting, so direct evidence for vestibular-vertigo-specific vomiting is limited. [2]
  • Dopamine-receptor blockade with metoclopramide is associated with extrapyramidal effects, including tardive dyskinesia. [3]

Initiation Thresholds or Indications

  • Antiemetic use is indicated for symptomatic control of nausea and vomiting while diagnostic evaluation for serious causes (including posterior circulation stroke in acute vestibular syndrome) is performed. [1]

Common Pitfalls to Avoid

  • Metoclopramide should not be used for prolonged duration because of extrapyramidal adverse effects, including tardive dyskinesia. [3]

Targets or Goals of Therapy

  • The clinical goal is reduction of nausea and prevention of further vomiting while ongoing evaluation proceeds for acute vestibular syndrome. [1], [2]

Related Questions